Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-12-000120
Filing Date
2012-01-04
Accepted
2012-01-04 16:06:22
Documents
1
Period of Report
2011-12-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rdgdoc.html 4  
1 PRIMARY DOCUMENT rdgdoc.xml 4 4713
  Complete submission text file 0001437749-12-000120.txt   6398
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Issuer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 1256 BRIARCLIFF ROAD N.E. EMTECH BIO SUITE 500 ATLANTA GA 30306
Business Address
Kollintzas Dean G (Reporting) CIK: 0001378351 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52091 | Film No.: 12506156